Suppr超能文献

脂联素,一种新激素:其在糖尿病发病机制中的作用

[Adiponectin, a new hormone: its role in the pathogenesis of diabetes mellitus].

作者信息

Pankov Iu A

出版信息

Vestn Ross Akad Med Nauk. 2006(9-10):99-104.

Abstract

Adiponectin is a hormone of adipose tissue, activating lipid metabolism and other physiological functions. Adiponectin deficiency induces obesity and decreases insulin-regulated carbohydrate metabolism, thus leading to insulin resistance. Blood level of adiponectin falls in type 2 diabetes. Adiponectin receptors--AdipoR1 and AdipoR2--are proteins with 7 transmembrane domains, which are synthesized mostly in muscles and the liver and function in a close connection with G proteins. Obesity and diabetes lower the tissue concentration of the receptors, thus impeding adiponectin regulation of lipid exchange and lowering the effectiveness of the insulin control of carbohydrate exchange. Adiponectin also influences cardiovascular functions and prevents atherosclerosis and some of the other kinds of vascular pathology.

摘要

脂联素是一种脂肪组织激素,可激活脂质代谢及其他生理功能。脂联素缺乏会导致肥胖,并降低胰岛素调节的碳水化合物代谢,从而导致胰岛素抵抗。2型糖尿病患者的血液中脂联素水平会下降。脂联素受体——AdipoR1和AdipoR2——是具有7个跨膜结构域的蛋白质,主要在肌肉和肝脏中合成,并与G蛋白密切相关发挥作用。肥胖和糖尿病会降低受体的组织浓度,从而阻碍脂联素对脂质交换的调节,并降低胰岛素对碳水化合物交换的控制效果。脂联素还会影响心血管功能,预防动脉粥样硬化和其他一些血管病变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验